you Welcome Envista’s time quarter us appreciate taking Thank XXXX earnings We you, Stephen. today. second the join call. to to
on focus quarter professionals digitize, accelerated partnering care. the personalize to to as oral anticipated, and we continue performance second in democratize with our As dental
an This quarter, margin margin we QX delivered of XX.X%. core revenue increased achieved our XXXX. points EBITDA growth Sequentially, XX basis versus X.X% adjusted EBITDA and of adjusted
We our positioned guidance accelerate single-digit EBITDA the year XXXX in of continue meet growth are or to and of margin performance our we full and greater. expect low second XX% to of to adjusted half
Howard priorities. detail, Before take more I I an over progress this perspective our environment turn offer then to our further in operating it provide discuss quarter to want second update to results the on our strategic opportunity current and towards on to
dental remains Globally, the dynamic. market
remains heavily risks uncertainties, demand macro of an to uneven creating environment. geopolitical resilient, including continue mind operating weigh both patient and While in patients the clinicians
in dental second came saw This not arch and weakness we widespread including mostly the of adult cancelling higher procedures. patients postponing cases in form procedures, quarter, treatments versus notable, weakness restorations. In but some full and the orthodontic the
Offsetting in dental this a further make weakness, care selective to in the demand for restorative continued commitment we saw clinician strength have practices. investments from their seen and
in we a digitize the growth DEXIS second a strong our to are Clinicians business practices, working in as IOS result, their quarter. and saw
As quarter on focus demand as we of second look remain we to execution. year, half and strengthen we performance to or the second to our expect resilient dental
it our our capabilities our execution continue our underpins margins to improve and continuously operational day we growth, portfolio. to EBS, rigor order serve better customers deliver and System, accelerate core every our Envista Long-term, work expand in use transform to Business shareholders. to and our our we
operations improving orthodontic include streamlining and Annual the successful action in a our and customer Kaizen business. examples product our our recent development of launch EBS in internal new President’s of an on Orascoptic business Two in and focus satisfaction
dentists all dental segment. and our leading dental our provider surgeons, For The orthodontists, operates Technologies of hygienists. with is Orascoptic including portfolio, those familiar for full business & of you loupes Specialty a oral within less Products professionals,
towards the a traditionally to use dental need a tool and predominantly leadership female hygienist that a market, Orascoptic the of underserved. targeted innovation the market the team growth, Recognizing drive to been customer has the Elevate generation design loupes, EBS RDH next
is designed are prioritizing while and The fashion-centric a option. to a RDH titanium It’s affordable. Elevate discomfort, custom with frame designs style eliminate quality a that still lightweight high
our our plans, great satisfaction. rapid debut, growth adoption its we demonstration and igniting is EBS business. improving a of Since single-digit accelerate growth recent how have high This product seen development contributing this in utilizing customer to can
advancing continuous President’s Ormco our at EBS to throughout In leadership driving aimed journey organization. business. at our while orthodontic the second Kaizen, improvement the team ran Turning quarter, the
on During team a orthodontics the was Kaizens employees. individual Kaizen XX over concentrated week a Each standardized, focused different was improved. that the and ran simplified long process involving XXX [ph],
and of successfully journey customer’s annual we including identified Demand consistently team and improving concrete improvements savings, in enhancing over our margins. experience. Our produce is in impact step million another consistency Spark while implemented that cost our our full business, $X the -- orthodontic positively
Focus QX, was performance driven on Once sustained perform in again, to drive while able -- significant on also our sequentially. our in by uniquely continues Spark orthodontic digits the positioned progress to well, growing Spark double business year-over-year focusing Aligners. growth, our Clear
Spark case. increasing revenue the continue doctors positioned and to doctors, per well We contribute is Envista’s EBS adding volumes Spark leverage formula to existing consistently case to to long-term and growth new are at growth. our growing drive we
continues system sanctions of of Russia, with bracket U.S., more our to was Ultima. orthodontist faster, XX% In impacted In our Europe, progress control continue for provides U.S. to bracket of more on finishing. make wire now more Ultima accelerate. and and penetration Damon precise sales consists Damon we products Damon the than wire While solution traditional This innovative business our by worldwide. negatively
in impacted growth by America. solutions Our tooth in for replacements of low weakness geographies solid with and North single in digits implant-based declined across most declines Russia the pockets quarter
for accelerated as as In we in an pricing, of value-based meaningful offsetting mid-single-digit, well driven demand China, implants, grew volumes increased gain through by impact the VBP, share.
the Biocare in this encouraged Nobel competitors pricing to clinicians and has narrowed our solutions. difference local trade implant has VBP many leading to market up the and other between
quarter the XXXX, temporary continued price basis expansion impact in Russia, margin first and reductions to an the VBP to in sequentially our our growth of expected, reduction a XX improved sales This of As despite China the high XX.X%. occurred investments margin initiatives. adjusted over increasing EBITDA long-term points
less structural leverage a manage optimization, focus controls, systematic To to margins businesses geographies. EBS deemphasizing cost of reductions through and non-strategic profitable on and price cost and
in second the margin of to full remain in track will guidance, investments XXXX expect growth. to year We expand on meaningful we and long-term making while deliver half
it IOS business is focused differentiated year, remains included one DEXIS improvements for our margin well and We underpenetrated capitalize stronger contributing growth in The growth-oriented both building and and in and in our than this growth within business. a DEXIS positioned Having remain & more Consumables area. core is IOS now to growth to IOS and market Equipment on our portfolio. owned is
In July, we the Osteogenics of Biomaterials reached the one-year acquisition. anniversary
Moving be & reported within Products Technologies forward, Osteogenics will as the segment. core growth Specialty
business growth or contribute core This be businesses accretive beyond. greater our XXXX well in to XX are points expected will and sales in of to XXXX. for growth Envista to basis Combined, perform and continues both acquired
see the additional While today, we moves made strategic we excited that about we portfolio. improve opportunities our are to further have
and a pursuing to opportunities. strategic partnerships to driven robust and deployment. EBS of cultivating investments disciplined utilize inorganic continuously a We to approach pipeline capital M&A our and new We’re manage committed approach
call quarter Howard over on more go turn financials now provide I will our to performance. and through the details to our segment second